Xponance Inc. increased its stake in shares of Hamilton Lane Incorporated (NASDAQ:HLNE – Free Report) by 6.3% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 5,662 shares of the company’s stock after acquiring an additional 335 shares during the period. Xponance Inc.’s holdings in Hamilton Lane were worth $838,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. CBIZ Investment Advisory Services LLC lifted its position in shares of Hamilton Lane by 27.0% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 287 shares of the company’s stock worth $43,000 after purchasing an additional 61 shares in the last quarter. Farther Finance Advisors LLC raised its holdings in Hamilton Lane by 283.3% in the fourth quarter. Farther Finance Advisors LLC now owns 299 shares of the company’s stock valued at $44,000 after acquiring an additional 221 shares in the last quarter. Icon Wealth Advisors LLC acquired a new stake in Hamilton Lane in the third quarter valued at $111,000. Harvest Fund Management Co. Ltd acquired a new position in Hamilton Lane during the 3rd quarter worth $127,000. Finally, Associated Banc Corp bought a new stake in shares of Hamilton Lane in the 3rd quarter worth about $212,000. Hedge funds and other institutional investors own 97.40% of the company’s stock.
Hamilton Lane Price Performance
Shares of HLNE opened at $155.89 on Tuesday. Hamilton Lane Incorporated has a 12 month low of $107.22 and a 12 month high of $203.72. The company has a debt-to-equity ratio of 0.34, a current ratio of 4.19 and a quick ratio of 4.19. The stock has a fifty day moving average price of $153.46 and a 200 day moving average price of $164.98. The company has a market cap of $8.64 billion, a P/E ratio of 28.76 and a beta of 1.28.
Hamilton Lane Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, April 4th. Stockholders of record on Friday, March 14th will be issued a dividend of $0.49 per share. The ex-dividend date of this dividend is Friday, March 14th. This represents a $1.96 dividend on an annualized basis and a dividend yield of 1.26%. Hamilton Lane’s dividend payout ratio (DPR) is presently 36.16%.
Analysts Set New Price Targets
A number of research firms recently commented on HLNE. The Goldman Sachs Group downgraded Hamilton Lane from a “neutral” rating to a “sell” rating and set a $139.00 price target for the company. in a research note on Monday, January 6th. Wells Fargo & Company decreased their target price on Hamilton Lane from $169.00 to $152.00 and set an “equal weight” rating for the company in a research report on Thursday, March 20th. Oppenheimer raised Hamilton Lane from a “market perform” rating to an “outperform” rating and set a $186.00 price target on the stock in a research report on Tuesday, January 21st. Finally, Keefe, Bruyette & Woods lifted their price objective on shares of Hamilton Lane from $158.00 to $168.00 and gave the stock a “market perform” rating in a report on Wednesday, February 5th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and one has issued a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $170.71.
Get Our Latest Stock Report on Hamilton Lane
About Hamilton Lane
Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.
Further Reading
- Five stocks we like better than Hamilton Lane
- How to Use the MarketBeat Dividend Calculator
- Super Micro Stock: $7.2M Call Options Signal Big Upside Potential
- Top Biotech Stocks: Exploring Innovation Opportunities
- Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch
- P/E Ratio Calculation: How to Assess Stocks
- D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst?
Receive News & Ratings for Hamilton Lane Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hamilton Lane and related companies with MarketBeat.com's FREE daily email newsletter.